Journalartikel
Autorenliste: Reuss, Reinhard; Retzlaff, Kerstin; Vogel, Sabine; Franke, Folker Ernst; Oschmann, Patrick
Jahr der Veröffentlichung: 2007
Seiten: 356-359
Zeitschrift: Central European Journal of Medicine
Bandnummer: 2
Heftnummer: 3
ISSN: 1895-1058
Open Access Status: Hybrid
DOI Link: https://doi.org/10.2478/s11536-007-0025-3
Verlag: Springer Verlag
Abstract:
Three weeks after the administration of intravenous methylprednisolone therapy, a 42-year-old female patient suffering from relapsinog-remitting multiple sclerosis (RR-MS) presented with a profound elevation of liver transaminases (GOT 485 U/1, GPT 1082 U/1, glutamyl transpeptidase 170 U/1). Liver biopsy revealed a profound, still active hepatitis with portal lymphocytic infiltration and fibrosis. Most likely, existing acute hepatitis was of autoinimune origin and emerged from an immune rebound phenomenon after immunosuppressive therapy. (c) Versita Warsaw and Sprinaer-Verlag Berlin Heidelberg. All rights reserved.
Zitierstile
Harvard-Zitierstil: Reuss, R., Retzlaff, K., Vogel, S., Franke, F. and Oschmann, P. (2007) Autoinimune hepatitis after high-dose intravenous methylprednisolone pulse in RR-MS, Central European Journal of Medicine, 2(3), pp. 356-359. https://doi.org/10.2478/s11536-007-0025-3
APA-Zitierstil: Reuss, R., Retzlaff, K., Vogel, S., Franke, F., & Oschmann, P. (2007). Autoinimune hepatitis after high-dose intravenous methylprednisolone pulse in RR-MS. Central European Journal of Medicine. 2(3), 356-359. https://doi.org/10.2478/s11536-007-0025-3
Schlagwörter
AUTOIMMUNE HEPATITIS; methylprednisolone; multiple sclerosis; OPHTHALMOPATHY; rebound phenomenon; transaminases
